These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 22781608

  • 41. B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
    Zaja F, Vianelli N, Sperotto A, De Vita S, Iacona I, Zaccaria A, Masolini P, Tomadini V, Tani M, Molinari AL, Baccarani M, Fanin R.
    Haematologica; 2003 May; 88(5):538-46. PubMed ID: 12745273
    [Abstract] [Full Text] [Related]

  • 42. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
    Latifzadeh SZ, Entezari V.
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
    [Abstract] [Full Text] [Related]

  • 43. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
    Riksen NP, Keuning JJ, Vreugdenhil G.
    Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
    [Abstract] [Full Text] [Related]

  • 44. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.
    Giagounidis AA, Anhuf J, Schneider P, Germing U, Söhngen D, Quabeck K, Aul C.
    Eur J Haematol; 2002 Aug; 69(2):95-100. PubMed ID: 12366712
    [Abstract] [Full Text] [Related]

  • 45. Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia.
    Pusiol A, Cesaro S, Nocerino A, Picco G, Zanesco L, Bisogno G.
    Eur J Pediatr; 2004 Jun; 163(6):305-7. PubMed ID: 15346911
    [Abstract] [Full Text] [Related]

  • 46. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.
    Parodi E, Nobili B, Perrotta S, Rosaria Matarese SM, Russo G, Licciardello M, Zecca M, Locatelli F, Cesaro S, Bisogno G, Giordano P, De Mattia D, Ramenghia U.
    Int J Hematol; 2006 Jul; 84(1):48-53. PubMed ID: 16867902
    [Abstract] [Full Text] [Related]

  • 47. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA, RITP study group.
    Lancet; 2015 Apr 25; 385(9978):1653-61. PubMed ID: 25662413
    [Abstract] [Full Text] [Related]

  • 48. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D.
    Hematology; 2012 Apr 25; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [Abstract] [Full Text] [Related]

  • 49. [Absence of response to rituximab in patients with refractory primary immune thrombocytopenia].
    Ma H, Wang Y, Sun L, Gong H.
    Zhonghua Yi Xue Za Zhi; 2014 Oct 21; 94(38):3011-3. PubMed ID: 25547706
    [Abstract] [Full Text] [Related]

  • 50. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP).
    Alasfoor K, Alrasheed M, Alsayegh F, Mousa SA.
    Ann Hematol; 2009 Mar 21; 88(3):239-43. PubMed ID: 18704420
    [Abstract] [Full Text] [Related]

  • 51. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A.
    J Intern Med; 2009 Nov 21; 266(5):484-91. PubMed ID: 19549092
    [Abstract] [Full Text] [Related]

  • 52. Rituximab for the treatment of acute refractory ITP.
    Kim SG, Whyte D, Pashankar FD.
    J Pediatr Hematol Oncol; 2014 Apr 21; 36(3):e149-51. PubMed ID: 23669737
    [Abstract] [Full Text] [Related]

  • 53. Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.
    Mahévas M, Ebbo M, Audia S, Bonnotte B, Schleinitz N, Durand JM, Chiche L, Khellaf M, Bierling P, Roudot-Thoraval F, Godeau B, Michel M.
    Am J Hematol; 2013 Oct 21; 88(10):858-61. PubMed ID: 23798363
    [Abstract] [Full Text] [Related]

  • 54. [Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab].
    Toubi E.
    Harefuah; 2012 Nov 21; 151(11):620-1, 655. PubMed ID: 23367731
    [Abstract] [Full Text] [Related]

  • 55. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
    Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P.
    Blood; 2008 Aug 15; 112(4):999-1004. PubMed ID: 18463354
    [Abstract] [Full Text] [Related]

  • 56. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, Sarmiento E, Micheloud D, Fernandez-Cruz E.
    Ann N Y Acad Sci; 2005 Jun 15; 1051():666-71. PubMed ID: 16127007
    [Abstract] [Full Text] [Related]

  • 57. [Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab].
    Kawachi Y, Ide M, Uchida T, Setsu K.
    Rinsho Ketsueki; 2003 Jan 15; 44(1):31-3. PubMed ID: 12649836
    [Abstract] [Full Text] [Related]

  • 58. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.
    Pasa S, Altintas A, Cil T, Danis R, Ayyildiz O.
    J Thromb Thrombolysis; 2009 Apr 15; 27(3):329-33. PubMed ID: 18311541
    [Abstract] [Full Text] [Related]

  • 59. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura.
    Bennett CM, Rogers ZR, Kinnamon DD, Bussel JB, Mahoney DH, Abshire TC, Sawaf H, Moore TB, Loh ML, Glader BE, McCarthy MC, Mueller BU, Olson TA, Lorenzana AN, Mentzer WC, Buchanan GR, Feldman HA, Neufeld EJ.
    Blood; 2006 Apr 01; 107(7):2639-42. PubMed ID: 16352811
    [Abstract] [Full Text] [Related]

  • 60. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
    Moschovi M, Trimis G, Pergantou H, Platokouki H, Vrachnou E, Tzortzatou-Stathopoulou F.
    J Paediatr Child Health; 2005 Jul 01; 41(7):384-6. PubMed ID: 16014149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.